semaglutide shortage 2025 The Ozempic is over Semaglutide and Tirzepatide No Longer

A new study found that semaglutide, a medication used to treat obesity and manage Type 2 diabetes, was associated with lower ideations of suicide compared to other medications.

Read more here: #WeightWatchers #GLP1 #Ozempic #DiabetesCare #NewTreatment

Professor Ania Jastreboff, MD, PhD Yale University provided an overview #ADA2026 of the TRIUMPH-1 trial for Retatrutide, the investigational triple G medicine from Eli Lilly and Company The unique trial design provided insights beyond #weightloss #obesity and also encompassed relevant endpoints for co-morbidities such as knee osteoarthritis and obstructive sleep apnea, two comorbidities highly sensitive to weight loss

Genetic predispositions in GLP-1 receptor pathways and individual biomarkers may help inform personalized selection conversations with providers